Quick Answer
Leucine Muscle Recovery Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Skeletal muscle disuse in older individuals (>65 years old) increases fall risk, hospitalization, and chronic disease development and accelerates age-induced muscle loss (sarcopenia) [,].
Key Takeaways
- 011 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Skeletal muscle disuse in older individuals (>65 years old) increases fall risk, hospitalization, and chronic disease development and accelerates age-induced muscle loss (sarcopenia) [,]. [Petrocelli Jonathan J. (2020)]
- 02Disuse-induced muscle atrophy and weakness and prolonged recovery from disuse in aging contribute to reduced life- and healthspan as skeletal muscle is important for whole-body glucose regulation [], postural stability/balance to prevent falls [], and strength to perform activities of daily living []. [Petrocelli Jonathan J. (2020)]
- 03Below we will present evidence that the SIRT1–AMPKα–PGC-1α signaling axis is targeted by several nutritional and pharmaceutical interventions and thus could be suitable translatable solutions to prevent disuse-induced muscle atrophy and improve recovery from disuse in older adults. [Petrocelli Jonathan J. (2020)]
- 04During recovery from disuse (e.g., surgery, injury, illness), older individuals experience delayed muscle size and strength recovery compared to their younger counterparts [,,,,,], a phenotype recapitulated in aged rodents [,]. [Petrocelli Jonathan J. (2020)]
The current Migaku evidence database contains 2 reusable source documents for Leucine Muscle Recovery Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Skeletal muscle disuse in older individuals (>65 years old) increases fall risk, hospitalization, and chronic disease development and accelerates age-induced muscle loss (sarcopenia) [,]. [Petrocelli Jonathan J. (2020); evidence level 3]
- Disuse-induced muscle atrophy and weakness and prolonged recovery from disuse in aging contribute to reduced life- and healthspan as skeletal muscle is important for whole-body glucose regulation [], postural stability/balance to prevent falls [], and strength to perform activities of daily living []. [Petrocelli Jonathan J. (2020); evidence level 3]
- Below we will present evidence that the SIRT1–AMPKα–PGC-1α signaling axis is targeted by several nutritional and pharmaceutical interventions and thus could be suitable translatable solutions to prevent disuse-induced muscle atrophy and improve recovery from disuse in older adults. [Petrocelli Jonathan J. (2020); evidence level 3]
- During recovery from disuse (e.g., surgery, injury, illness), older individuals experience delayed muscle size and strength recovery compared to their younger counterparts [,,,,,], a phenotype recapitulated in aged rodents [,]. [Petrocelli Jonathan J. (2020); evidence level 3]
- [Conclusion] LEAA consumption suppressed exercise-induced elevation of muscle damage markers in blood, which suggests that LEAA could attenuate muscle damage and aid muscle recovery. [Matsui Y (2019); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources